StephanThomeMD

Oncology • Rochester, MN

Hematologic Oncology

Assistant Professor, Department of Oncology, Division of Community Oncology, Mayo Clinic Rochester, Minnesota

Join to view full profile

Dr. Thome is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Thome's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-594-2929
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1997 - 2001
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1995 - 1997
University of Ulm Faculty of MedicineClass of 1993

Certifications & Licensure

IA State Medical License 2003 - 2025
NE State Medical License 2001 - 2024
MN State Medical License 1998 - 2024
WI State Medical License 2004 - 2021
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane Start of enrollment: 2003 Jun 01
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study
Elizabeth J. Cathcart-Rake, David Zahrieh, Deanne Smith, Susan Young, Shaylene A. McCue, Amanda O’Connor, Stephan D. Thomé, Mario E. Lacouture, Terra Register, Jill Pi...> ;Supportive Care in Cancer. 2021 Apr 13
40 citations
Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone
Nelson Leung, Stephan D. Thomé, Angela Dispenzieri> ;Haematologica. 2018 Mar 1
47 citations
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented...
Ronald S. Go, Jeffrey L. Winters, Nelson Leung, David L. Murray, Maria Alice V. Willrich, Roshini S. Abraham, Hatem Amer, William J. Hogan, Ariela L. Marshall, Sanjeev...> ;Mayo Clinic Proceedings. 2016 Sep 1
1 citations
Edoxaban was noninferior to warfarin for preventing recurrent venous thromboembolism, with less bleeding
Stephan D. Thomé> ;Annals of Internal Medicine. 2014 Jan 21
26 citations
Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MG...
Sandra Grass, Klaus Dieter Preuss, Stephan D. Thomé, Dennis D. Weisenburger, Vinetta Witt, Jane F. Lynch, Florian Zettl, Lorenz Trümper, Natalie Fadle, Evi Regitz, Hen...> ;Blood. 2011 Jul 21
Familial plasma cell disorders and associated cancers.
Henry T. Lynch, Carrie Snyder, Jane F. Lynch, Stephan D. Thomé> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Feb 1
22 citations
Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators
Aditya Bardia, Charles L. Loprinzi, Axel Grothey, Garth D. Nelson, Steven R. Alberts, Smitha Menon, Stephan D. Thomé, Sharlene Gill, Daniel J. Sargent> ;Seminars in Oncology. 2010 Feb 1
7 citations
Initial report of a family registry of multiple myeloma
Elizabeth Ann Coleman, Henry T. Lynch, Carol A. Enderlin, Beth Stewart, Stephan D. Thomé, Robert L. Kennedy, Tami Richardson-Nelson, Bart Barlogie> ;Cancer Nursing. 2009 Nov 1
1 citations
MGUS, multiple myeloma, and paratarg-7
Henry T. Lynch, Stephan D. Thomé> ;The Lancet. Oncology. 2009 Oct 1
27 citations
Familial multiple myeloma
Henry T. Lynch, Stephan D. Thomé> ;Blood. 2009 Jul 23
Adjuvant chemotherapy for resected stage II and III colon cancer: Comparison of widely used two prognostic calculators.
Bardia A, Loprinzi C, Grothey A, Nelson G, Alberts S, Patiyil S, Thome S, Gill S, Sargent D> ;J. Clin. Oncol.. 2009-05-20
1 citations
Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family.
Henry T. Lynch, Kelly M. Ferrara, Dennis D. Weisenburger, Warren G. Sanger, Jane F. Lynch, Stephan D. Thomé> ;Cancer Genetics and Cytogenetics. 2008 Oct 15
Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anaemia.
Stephan Thomé> ;Evidence-Based Medicine. 2008 Oct 1
Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anemia.
Stephan Thomé> ;ACP Journal Club. 2008 Aug 19
60 citations
Familial Myeloma: Study of a Unique Family
Henry T. Lynch, Kelly M. Ferrara, Bart Barlogie, Elizabeth Ann Coleman, Jane F. Lynch, Dennis D. Weisenburger, Warren G. Sanger, Patrice Watson, Henry Nipper, Vinetta ...> ;The New England Journal of Medicine. 2008 Jul 10
Family information service (FIS) in a BRCA1 extended family.
Lynch HT, Snyder C, Lynch J, Ghate S, Thome S> ;J. Clin. Oncol.. 2006-06-20
737 citations
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent, Stephan D. Thomé, Steven R. Alberts, Daniel G. Haller, Jacqueline Benedetti, Guido Francini, Lois E. Shepherd, J...> ;Journal of Clinical Oncology. 2004 May 15
8 citations
Determination of Potential Adjuvant Systemic Therapy Benefits for Patients With Resected Cutaneous Melanomas
Stephan D. Thomé, Charles L. Loprinzi, Michael P. Heldebrant> ;Mayo Clinic Proceedings. 2002 Sep 1
7 citations
Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas.
Ravi D. Rao, Stephan D. Thomé, Judith R. O'Fallon, John D. Earle, Robert P. Dinapoli, Jan C. Buckner> ;International Journal of Radiation Oncology, Biology, Physics. 2002 Jun 1
34 citations
Unusual presentation of multiple myeloma with unilateral visual loss and numb chin syndrome in a young adult.
Marie C. Hogan, Augustine S. Lee, Lawrence A. Solberg, Stephan D. Thomé> ;American Journal of Hematology. 2002 May 1
36 citations
Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.
David M. Menke, Amy Chadburn, Ethel Cesarman, Eric M. Green, James R. Berenson, Jonathan W. Said, Markus Tiemann, Reza Parwaresch, Stephan D. Thomé> ;American Journal of Clinical Pathology. 2002 Feb 1
68 citations
Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer
Charles L. Loprinzi, Stephan D. Thomé> ;Journal of Clinical Oncology. 2001 Feb 15
36 citations
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report.
Patrick J. Stiff, Judith A. Veum-Stone, Hillard M. Lazarus, Lois Ayash, John R. Edwards, Armand Keating, John P. Klein, David J. Oblon, Thomas C. Shea, Stephan Thomé,...> ;Annals of Internal Medicine. 2000 Oct 3
2 citations
71-Year-Old Woman With Palpitations and Dyspnea on Exertion
Stephan D. Thomé, Dietlind L. Wahner-Roedler> ;Mayo Clinic Proceedings. 1998 Nov 1
10 citations
Dimethylsulphoxide-induced serum hyperosmolality after cryopreserved stem-cell graft
Stephan Thomé, Janet Craze, Chris Mitchell> ;Lancet. 1994 Nov 19
Join now to see all

Press Mentions

College Professor Beats Breast Cancer with Her Hometown TeamJune 1st, 2017

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member

Other Languages

German, French

Hospital Affiliations

Mayo Clinic Hospital - RochesterRochester, Minnesota